Establishment Labs Holdings Inc. (ESTA): Price and Financial Metrics
GET POWR RATINGS... FREE!
ESTA POWR Grades
- Sentiment is the dimension where ESTA ranks best; there it ranks ahead of 97.04% of US stocks.
- The strongest trend for ESTA is in Value, which has been heading down over the past 31 weeks.
- ESTA ranks lowest in Quality; there it ranks in the 25th percentile.
ESTA Stock Summary
- ESTA's went public 2.89 years ago, making it older than only 7.89% of listed US stocks we're tracking.
- With a price/sales ratio of 19.79, Establishment Labs Holdings Inc has a higher such ratio than 90% of stocks in our set.
- In terms of volatility of its share price, ESTA is more volatile than 93.18% of stocks we're observing.
- Stocks with similar financial metrics, market capitalization, and price volatility to Establishment Labs Holdings Inc are HBIO, FLNT, TMDX, MTW, and HLIT.
- ESTA's SEC filings can be seen here. And to visit Establishment Labs Holdings Inc's official web site, go to www.establishmentlabs.com.
ESTA Price Target
For more insight on analysts targets of ESTA, see our ESTA price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.
| Average Price Target | $79.83 | Average Broker Recommendation | 1.33 (Strong Buy) |
ESTA Stock Price Chart Interactive Chart >
ESTA Price/Volume Stats
| Current price | $79.17 | 52-week high | $84.49 |
| Prev. close | $79.07 | 52-week low | $14.61 |
| Day low | $78.52 | Volume | 80,900 |
| Day high | $80.31 | Avg. volume | 103,253 |
| 50-day MA | $72.38 | Dividend yield | N/A |
| 200-day MA | $46.44 | Market Cap | 1.88B |
Establishment Labs Holdings Inc. (ESTA) Company Bio
Establishment Labs Holdings Inc., a medical technology company, designs, develops, manufactures, and markets medical devices for aesthetic plastic surgery, reconstructive plastic surgery, and aesthetic dermatology. The company primarily offers silicone gel-filled breast implants under Motiva Implants brand name. It also provides Divina 3D simulation systems to plastic surgeons for use in pre-surgical patient consultations and planning; and distributes Puregraft line of products that is used to remove blood, lipids, and other components from adipose tissue. The company sells its products through exclusive distributors and direct sales force in 60 countries worldwide. The company was founded in 2004 and is based in Alajuela, Costa Rica.
Latest ESTA News From Around the Web
Below are the latest news stories about Establishment Labs Holdings Inc that investors may wish to consider to help them evaluate ESTA as an investment opportunity.
Establishment Labs Announces Appointments of Heather Brennan as Head of U.S. Commercial Operations and Neeta Toprani as General Counsel & Corporate SecretaryEstablishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, announced today that Heather Brennan has joined the company as Head of U.S. Commercial Operations and Neeta Toprani has joined as General Counsel & Corporate Secretary. |
Establishment Labs Announces Participation in the Jefferies Virtual Healthcare ConferenceEstablishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced that CEO and Founder Juan José Chacón-Quirós and Chief Financial Officer Renee Gaeta will participate in the Jefferies Virtual Healthcare Conference, which is being held June 1-4, 2021. Mr. Chacón-Quirós and Mrs. Gaeta are scheduled to speak to conference attendees at 2:00 pm ET on Friday, June 4, 2021. |
Establishment Labs Announces Participation in the UBS Global Healthcare Virtual ConferenceEstablishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced that CEO and Founder Juan José Chacón-Quirós and Chief Financial Officer Renee Gaeta will participate in the UBS Global Healthcare Virtual Conference, which is being held May 24-26, 2021. Mr. Chacón-Quirós and Mrs. Gaeta are scheduled to speak to conference attendees at 9:00 am ET on Monday, May 24, 2021. |
Establishment Labs Holdings Inc. (ESTA) Reports Q1 Loss, Tops Revenue EstimatesEstablishment Labs Holdings Inc. (ESTA) delivered earnings and revenue surprises of 9.38% and 20.38%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock? |
Establishment Labs Reports Record First Quarter 2021 Financial Results and Raises Full Year GuidanceEstablishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced its financial results for the first quarter ended March 31, 2021 and provided updated 2021 guidance. |
ESTA Price Returns
| 1-mo | 19.95% |
| 3-mo | 34.25% |
| 6-mo | 151.33% |
| 1-year | 338.37% |
| 3-year | N/A |
| 5-year | N/A |
| YTD | 110.33% |
| 2020 | 36.08% |
| 2019 | 0.88% |
| 2018 | N/A |
| 2017 | N/A |
| 2016 | N/A |
Continue Researching ESTA
Here are a few links from around the web to help you further your research on Establishment Labs Holdings Inc's stock as an investment opportunity:Establishment Labs Holdings Inc (ESTA) Stock Price | Nasdaq
Establishment Labs Holdings Inc (ESTA) Stock Quote, History and News - Yahoo Finance
Establishment Labs Holdings Inc (ESTA) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...